TheraRadar
← Back
Data updated: Mar 29, 2026

ABC HOLDING

CardiovascularGastroenterology
Generics

ABC HOLDING is a generic drug manufacturer focused on Cardiovascular, Gastroenterology.

1977
Since
7
Drugs
-
Trials
9
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

MECLIZINE HYDROCHLORIDE 2026-01-06
Labeling
PHENTERMINE HYDROCHLORIDE 2025-07-24
Labeling
HYDROCHLOROTHIAZIDE 2024-09-19
Manufacturing (CMC)
HYDROCHLOROTHIAZIDE 2024-08-22
Labeling
HYDROCHLOROTHIAZIDE 2024-04-30
Labeling
HYDROCHLOROTHIAZIDE 2024-04-30
Labeling
HYDROCHLOROTHIAZIDE 2024-04-30
Labeling
HYDROCHLOROTHIAZIDE 2024-04-04
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%
1 drugs
Gastroenterology 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

BAUSCH specialty
Cardiovascular, Gastroenterology
APOTHECON specialty
Cardiovascular, Gastroenterology
VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Gastroenterology
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology